Litcius/Paper detail

miRNA Detection for Prostate Cancer Diagnosis by miRoll-Cas: miRNA Rolling Circle Transcription for CRISPR-Cas Assay

Xiaowei Ma, Fei Zhou, Donglei Yang, Yun Chen, Min Li, Pengfei Wang

2023Analytical Chemistry42 citationsDOIOpen Access PDF

Abstract

Micro-RNA (miRNA) emerges as a promising type of biomarker for cancer diagnosis. There is an urgent need for developing rapid, convenient, and precise miRNA detection methods that may be conducted with limited laboratory facilities, especially in underdeveloped areas. Herein, we developed a miRNA detection method termed miRoll-Cas, where miRNA is first amplified by rolling circle transcription and then subject to CRISPR-Cas13a assay. Using miRoll-Cas, we realized the sensitive detection of multiple cancer-relevant miRNA markers (miR21, miR141, and Let7b) and specifically identified other variants of the Let7 family, which can accurately discriminate prostate cancer patients from healthy people. We envision that miRoll-Cas may be readily translated to clinical applications in the diagnosis of a variety of diseases beyond cancer.

Topics & Concepts

microRNAProstate cancerCRISPRComputational biologyBiomarkerClinical diagnosisCancerCancer detectionRNAGeneBiologyGeneticsMedicineClinical psychologyMicroRNA in disease regulationRNA Interference and Gene DeliveryCRISPR and Genetic Engineering
miRNA Detection for Prostate Cancer Diagnosis by miRoll-Cas: miRNA Rolling Circle Transcription for CRISPR-Cas Assay | Litcius